Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis.
第一作者:
Hans D,Theiss
第一单位:
Medical Department I, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany.
作者:
医学主题词
动物(Animals);抗原, CD34(Antigens, CD34);苄胺类(Benzylamines);趋化因子CXCL12(Chemokine CXCL12);二肽基肽酶4(Dipeptidyl Peptidase 4);剂量效应关系, 药物(Dose-Response Relationship, Drug);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);心脏功能试验(Heart Function Tests);造血干细胞动员(Hematopoietic Stem Cell Mobilization);杂环化合物(Heterocyclic Compounds);小鼠(Mice);模型, 生物学(Models, Biological);心肌梗死(Myocardial Infarction);新生血管化, 生理性(Neovascularization, Physiologic);寡肽类(Oligopeptides);灌流(Perfusion);原癌基因蛋白质类c-kit(Proto-Oncogene Proteins c-kit);受体, CXCR4(Receptors, CXCR4);干细胞移植(Stem Cell Transplantation);存活率分析(Survival Analysis)
DOI
10.1016/j.scr.2011.05.003
PMID
21752744
发布时间
2022-03-16
- 浏览0
Stem cell research
244-55页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



